OncoTherapy Science: Change report.
OncoTherapy Science: Report on Corporate Governance: June 5, 2024.
OncoTherapy Science: Announcements of individual stocks regarding the massive exercise of the 36th subscription rights (with exercise price adjustment clause) by third-party allocation.
OncoTherapy Science: Notice regarding the monthly exercise status of the 36th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment
OncoTherapy Science: 2024 Annual General Meeting of Shareholders Convocation Notice and Shareholders' Meeting Materials
ONCOTHERAPY SCIENCE: Change Report
ONCOTHERAPY SCIENCE: Change Report
ONCOTHERAPY SCIENCE: Change Report
ONCOTHERAPY SCIENCE: Notice Concerning Mass Exercise of the 36th Stock Acquisition Rights (with Exercise Price Amendment Clauses) through Third-Party Allotment
ONCOTHERAPY SCIENCE: Change Report
ONCOTHERAPY SCIENCE: Notice Concerning Mass Exercise of the 36th Stock Acquisition Rights (with Exercise Price Amendment Clauses) through Third-Party Allotment
ONCOTHERAPY SCIENCE: Notice regarding differences between consolidated financial results for the fiscal year ending March 31, 2024 and results for the previous fiscal year
ONCOTHERAPY SCIENCE: Notice regarding the occurrence of extraordinary losses, etc.
ONCOTHERAPY SCIENCE: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
ONCOTHERAPY SCIENCE: Change Report
ONCOTHERAPY SCIENCE: Change Report
ONCOTHERAPY SCIENCE: Notice Concerning Mass Exercise of the 36th Stock Acquisition Rights (with Exercise Price Amendment Clauses) through Third-Party Allotment
ONCOTHERAPY SCIENCE: Change Report
ONCOTHERAPY SCIENCE: Notice regarding completion of acquisition and cancellation of the 35th Stock Acquisition Rights and completion of payment of the 36th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment
OncoTherapy Science: Notice Concerning Acquisition and Cancellation of the 35th Stock Acquisition Rights and the Issuance of the 36th Stock Acquisition Rights (with Exercise Price Amendment Clauses) through third-party allotment
No Data